Journal
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Volume 49, Issue 1, Pages 55-63Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jpba.2008.10.002
Keywords
Lamivudine; Stress Studies; Stability-indicating assay method; MSn; LC-MS/TOF; Degradation pathway; Mechanism
Categories
Funding
- M/s Thermo Fischer Scientific (Mumbai, India)
Ask authors/readers for more resources
Lamivudine was subjected to forced decomposition conditions of hydrolysis (neutral, acidic and alkaline), oxidation, photolysis and thermal stress, as suggested in the ICH guideline Q1A(R2). The drug showed instability in acid and alkali, while it remained stable in neutral conditions. It also degraded extensively under oxidative environment. It remained stable to light and thermal stress. In total, five degradation products were formed, which could be separated by LC on a C18 column using a gradient method. To characterize the products, first a complete fragmentation pathway of the drug was established by carrying out multi-stage (MSn) and MS/TOF accurate mass studies. The same was compared to fragment pattern of the degradation products resulting from LC-MS/TOF studies. The accurate mass values obtained from LC-MS/TOF were used to obtain elemental compositions, and the total information helped in identification of the degradation products. Subsequently, degradation pathway of the drug was laid down, along with mechanisms of formation of the degradation products. There is no previous information on these aspects on the drug in the literature. (c) 2008 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available